We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

15 hedge funds and large institutions have $187K invested in Aethlon Medical in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

109% more capital invested

Capital invested by funds: $89.2K → $187K (+$97.6K)

0.01% more ownership

Funds ownership: 0.02% → 0.04% (+0.01%)

6% less funds holding

Funds holding: 16 → 15 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$86K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$31K
3
Two Sigma Investments
Two Sigma Investments
New York
+$6.13K
4
BBA
Baader Bank Aktiengesellschaft
Germany
+$1.62K
5
Citigroup
Citigroup
New York
+$985

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$18.3K
2
Jane Street
Jane Street
New York
-$13.2K
3
TSS
Two Sigma Securities
New York
-$8.26K
4
HF
HRT Financial
New York
-$5K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$549
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$102K +$86K +2,706 +12,300%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$45.9K +$31K +977 +386%
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.89K – – –
Two Sigma Investments
4
Two Sigma Investments
New York
$7.2K +$6.13K +193 New
TSS
5
Two Sigma Securities
New York
$6.41K -$8.26K -260 -60%
BBA
6
Baader Bank Aktiengesellschaft
Germany
$5.79K +$1.62K +51 +31%
TRCT
7
Tower Research Capital (TRC)
New York
$3.68K +$413 +13 +15%
BlackRock
8
BlackRock
New York
$3.42K – – –
Citigroup
9
Citigroup
New York
$1.16K +$985 +31 New
JP Morgan Chase
10
JP Morgan Chase
New York
$768 +$667 +21 New
Group One Trading
11
Group One Trading
Illinois
$568 – – –
Wells Fargo
12
Wells Fargo
California
$98 – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$68 – – –
Bank of America
14
Bank of America
North Carolina
$53 +$32 +1 New
Morgan Stanley
15
Morgan Stanley
New York
$42 – – –
BCWM
16
Bartlett & Co Wealth Management
Ohio
$12 – – –
TC
17
Truvestments Capital
Florida
$2 – – –
AF
18
Allworth Financial
California
$1 – – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$18.3K -458 Closed
Jane Street
20
Jane Street
New York
– -$13.2K -330 Closed
HF
21
HRT Financial
New York
– -$5K -126 Closed
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
– -$549 -14 Closed
ACM
23
Anfield Capital Management
California
– -$20 -1 Closed

AEMD Hedge Fund Activity: Q3 2024 in Review

15 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2024, worth a combined $187K — up 109% from $89.2K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of AEMD and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.

The largest buyer was UBS Group, adding an estimated $86K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $18.3K sold.

  • 15 institutional investors held Aethlon Medical (AEMD) as of Q3 2024, down from 16 in Q2 2024.
  • Funds reported $187K of Aethlon Medical stock for Q3 2024, up 109% quarter-over-quarter.
  • 4 funds opened new Aethlon Medical positions in Q3 2024 and 5 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q3 2024 was UBS Group, an estimated $86K added.
  • The largest Aethlon Medical seller in Q3 2024 was Susquehanna International Group, an estimated $18.3K sold.

Based on aggregated 13F filings for Q3 2024.